BioNexus Gene Lab Corp. Other Expenses
BioNexus Gene Lab Corp. (BGLC) reported Other Expenses of $916.95 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherExpenses · last filed 2024-11-15
- 2024-09-30: Other Expenses 9 month $916.95K.
- 2023-06-30: Other Expenses 6 month $5.29M.
| Period end | Other Expenses 6 month | Other Expenses 9 month |
|---|---|---|
| 2024-09-30 | $916.95K 10-Q · filed 2024-11-15 | |
| 2023-06-30 | $5.29M 10-Q · filed 2023-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |